SCHEMBL6177397

SCHEMBL6177397

O=CC1OCCS1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14427846 0.69
SCHEMBL27396889 0.62
SCHEMBL23566926 0.59
SCHEMBL27531922 0.58
SCHEMBL6693367 0.57
SCHEMBL1053963 0.57
SCHEMBL10577901 0.56
SCHEMBL2966236 0.55
SCHEMBL9243173 0.55
SCHEMBL826989 0.55

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114656654-B Modified lignin self-repairing conductive hydrogel and preparation method and application thereof 江苏理工学院 2023-07-11 CN claimed
CN-114656654-A Modified lignin self-repairing conductive hydrogel and preparation method and application thereof 江苏理工学院 2022-06-24 CN claimed
CN-110639025-B Polyamide-imide drug-loaded nanoparticle and application thereof 无锡市人民医院 2021-11-09 CN claimed
CN-110639025-A Polyamide-imide drug-loaded nanoparticle and application thereof 无锡市人民医院 2020-01-03 CN claimed
CN-101616586-B Heterocyclic receptor agonists for the treatment of diabetes and metabolic disorders CYMABAY THERAPEUTICS INC 2014-08-13 CN claimed
EP-1361223-B1 Method of manufacture of 1,3-oxathiolane nucleosides GILEAD SCIENCES INC (US) 2005-04-06 EP claimed
CN-114656654-B Modified lignin self-repairing conductive hydrogel and preparation method and application thereof 江苏理工学院 2023-07-11 CN disclosed
CN-114656654-A Modified lignin self-repairing conductive hydrogel and preparation method and application thereof 江苏理工学院 2022-06-24 CN disclosed
CN-103857288-B Amino-quinolines as kinase inhibitors 葛兰素史密斯克莱知识产权发展有限公司 2016-09-21 CN disclosed
CN-103874495-B As the amido quinazoline of inhibitors of kinases GlaxoSmithKline Intellectual Property Development Ltd. (GB) 2016-04-20 CN disclosed
CN-101616586-B Heterocyclic receptor agonists for the treatment of diabetes and metabolic disorders CYMABAY THERAPEUTICS INC 2014-08-13 CN disclosed
CN-102026636-B Oxymethylene aryl compounds and uses thereof METABOLEX INC 2014-07-16 CN disclosed
CN-102026636-A Oxymethylene aryl compounds and uses thereof METABOLEX INC 2011-04-20 CN disclosed
CN-101616586-A The heterocyclic receptor agonists of treatment diabetes and metabolic disorder METABOLEX INC 2009-12-30 CN disclosed